Related Experiment Videos
CJ-12,373, a novel topoisomerase II inhibitor: fermentation, isolation, structure elucidation and biological
T Inagaki1, K Kaneda, Y Suzuki
1Central Research Division, Pfizer Pharmaceuticals Inc., Aichi, Japan.
The Journal of Antibiotics
|April 17, 1998
Abstract:
A novel isochroman carboxylic acid CJ-12,373 was isolated from Penicillium sp. CL22557. CJ-12,373 inhibits both DNA gyrase-mediated supercoiling and relaxation without the formation of a cleavage intermediate, suggesting that CJ-12,373 inhibits DNA gyrase at a stage distinct from the religation step. CJ-12,373 is not selective for procaryotic DNA gyrase as it also inhibits relaxation mediated by eukaryotic topoisomerase II. The antimicrobial potency of CJ-12,373, however, is largely attributed to its inhibition of DNA gyrase.